CON vs OGN · P/E 18, rev $1.90B vs P/E 3.4, rev $6.40B
Concentra Group Holdings Parent, Inc. (CON) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Concentra Group Holdings Parent, Inc. (CON) is a medical care facilities company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported CON revenue for 2024-12-31 was $1.90B. Net income was $171.9M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. CON currently screens at market cap $3.18B and trailing P/E 17.9.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CON currently screens at market cap $3.18B and trailing P/E 17.9. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CON and OGN stock pages for the full models.
Not investment advice.